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Synthetic derivatives of γ-aminobutyric acid (GABA), theprincipal inhibitory neurotransmitter in the mammalian brain,
have been extensively used for the treatment of several nervous
system disorders including epilepsy, neuropathic pain, anxiety, and
social phobia.1 Several drugs such as Gabapentin and Pregabalin
have achieved rapid success in the past two decades.2 The use of an
enzymatic kinetic resolution in the manufacturing of Pregabalin3
was critical in providing an economical, high-yield synthesis of the
final drug. The chemistry has been further developed and im-
plemented by Pfizer, and the environmental benefits of racemizing
and recycling the wrong enantiomer have been demonstrated at
multiple metric ton scale.3 This prompted research to explore the
possibility of using a biocatalyst like the Thermomyces Lanuginosa
lipase in the resolution of related compounds, namely, 3-substi-
tuted-3-cyano-2-(ethoxycarbonyl)propanoic acid ethyl esters 2
(Scheme 1). Herein, we report high enantioselectivity of three
lipases toward a variety of aliphatic and aromatic substrates,
producing the corresponding enantiopure 2-carbethoxy-3-substi-
tuted-3-cyanopropionate salts 3.4 A general decarboxylation pro-
cedure for compounds 3 is also reported, yielding the final
enantiopure compounds 4. Alkaline hydrolysis and reduction of
these compounds by knownmethods produces the corresponding
β-substituted-γ-amino acids 6 without affecting the chiral center
generated in the enzymatic resolution.3,5,6
The substrates 2 were synthesized by a two-step method:
Knoevenagel condensation of the corresponding aldehyde with
diethyl malonate followed by nucleophilic cyanation of the R-β
unsaturated precursor 1. The initial Knoevenagel reaction was
carried out in n-heptane with piperidine/acetic acid as the
catalytic systemwith continuous removal of H2O, and proceeded
smoothly with good to high yields (Table 1). The resulting crude
products 1 are used after minimal workup and without purifica-
tion in the cyanation reaction. The cyanation reaction uses KCN
in ethanol, and also proceeds with moderate to high yields, and
the crude compound 2 thus produced can be used in the
enzymatic step without purification (Scheme 2).
Conceptually, the generation of compound 3 from 2 involves
the hydrolysis of one diastereotopic carboxyethyl group, a
desymmetrization of the prochiral C-2 center. The desired
outcome was to find an enzyme that could only perform such a
reaction on the S enantiomer of racemic 2 (kinetic resolution),
thus generating one (or two) diastereomers from a single
enantiomer at the C-3 chiral center, leaving behind the R
enantiomer of 2. Thus, the diastereoselectivity in the desymme-
trization reaction per se was not as important as the enantios-
electivity of the kinetic resolution, as the chirality at the C-2
center will be lost while converting 3 to the desired product 4.
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ABSTRACT: In this work, we utilized commercial lipases
(from Thermomyces lanuginosa, Rhizopus delemar, and Mucor
miehei) as biocatalysts for the efficient synthesis of precursors of
β-substituted-γ-amino acids. This biocatalytic route provides a
practical and efficient synthesis of a wide range of optically
active compounds by accepting a number of aliphatic and
aromatic 3-substituted-3-cyano-2-(ethoxycarbonyl)propanoic
acid ethyl esters (2) without compromising enantioselectivity
or yields. The resolution step allows for the nearly quantitative
recovery of the unreacted enantiomer of R-(2) as well as
the newly formed 3-substituted-3-cyano-2-(ethoxycarbonyl)-
propanoic acid (3) in high enantio and diastereoselectivity.
The use of a facile thermal decarboxylation of (3) in aqueous solution to produce 3-substituted-3-cyanopropanoic acid ethyl esters
(4) enable us to prepare a wide range of optically active precursors of β-Substituted-γ-Amino Acids.
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Standards to analyze the reaction were initially prepared by
base hydrolysis of one ester group in 2, followed by acidifica-
tion to produce carboxylic acids of general structure 3.
However, GC analysis of these products only displayed two
products, determined (by GC-MS) to be the two enantiomers
of 4, because of decarboxylation of 3 at elevated temperatures
(Scheme 3). To overcome this thermal decarboxylation, the
acids 3 were derivatized prior to GC analysis to give thermally
stable methyl ethyl esters 5, thus allowing for the determina-
tion of both the enantioselectivity and the diastereoselectivity
of the enzyme. The screening results (Table 2) indicate that T.
lanuginosa Lipase (Lipolase 100 L from Novozymes) does
have a broad substrate specificity for aliphatic derivatives of 2,
and limited or no selectivity for aromatic substituents exam-
ined (except substrate 2i). Interestingly, derivatives 2b and 2c
though accepted by lipolase, do display lower selectivity (E
values ∼100) than 2d, 2e, and 2f (E values >200). Lipolase did
not show activity with substrates 2g, 2h, 2j, and 2k, and this called
for the study of additional lipases.Rhizopus delemar lipase (LipaseD
“Amano”) and Mucor miehei lipase (Palatase 20000 L) demon-
strated high levels of activity and enantioselectivity with 2e as
previously reported,3 and were selected on this basis. These
lipases performed the efficient resolution on the aliphatic sub-
strates 2b and 2c as well as the 4 aromatic substrates not resolved
by Lipolase.
The E values16 were obtained from the enantiomeric excess
(% ee) of the product and of the remaining substrate at a given
conversion value (Table 2). Although the diastereoselectivity of
the lipases is not critical in this discussion, we note that for almost
all of the compounds reported, the enzymes were highly diaster-
eoselective as well as enantioselective. The absolute configura-
tion of the favored diastereomer of 3 produced in the enzymatic
reaction was not determined.
Once the resolution is complete, the desired product is present
as the potassium salt 3, which is easy separated from the
unreacted enantiomer of 2 by solvent extraction. The final step
to form 4 made used of a facile thermal decarboxylation of 3
(performed in the same aqueous phase obtained after re-
solution). This method was previously demonstrated by the
conversion of 3e to 4e,3 and it proved to be a general method for
all the substrates screened herein. The 2 h reflux enabled the
thermal decarboxylation of 3 to afford 4, which is obtained as a
water-insoluble oil/solid of high purity (Scheme 4). As an added
benefit, the water-soluble enzyme and other buffer components
that may interfere with the efficiency of subsequent steps are
removed without the need for additional purification.
This method provides a practical and efficient synthesis of a
wide range of optically active compounds. Several lipases were
identified with broad substrate scope including aliphatic and
aromatic compounds, high enantioselectivities and yields, allow-
ing the nearly quantitative recovery of both enantiomers. The
absence of purification steps and demonstrated scalability of the
reactions also allows this method to be used on an industrial scale
to give products in high yields. This has resulted in significant
environmental savings in terms of bothmaterial and energy usage
when applied to the synthesis of Pregabalin (6e).22
’EXPERIMENTAL METHODS
General Considerations. All 1H NMR spectra were obtained
at 400 MHz; 13C NMR data was obtained at 100 MHz. For the
chiral products we report single enantiomer GC traces on a
Chiraldex G-TA column (30 m), or HPLC traces on Chiralpak
HPLC columns. For enzymes commercially available as solids,
10% (w/v) solutions were prepared in 0.1 M potassium phos-
phate buffer of pH 7.0. The following products have previously
been reported, and can be found in the references: 1ak, 2ae,
4ab, 4g, 4ij. The remaining compounds are all properly
characterized by 1H and 13C NMR. The compounds 4 that have
been reported previously are reported as their racemic mixtures,
thus GC or HPLC traces of the single enantiomers are also
reported herein. Absolute (R/S) configurations were not deter-
mined for 4g, 4j, or 4k.
General Procedure for 3-Substituted-2-(ethoxycarbonyl)-
propanoic Acid Ethyl Esters (1). A solution was prepared of
diethyl malonate (1.0 equiv) and piperidine23 (0.1 equiv) in n-
heptane (30 mL). To this was added aldehyde (10.0 g) and
glacial acetic acid (0.1 equiv). The solution was refluxed under
DeanStark conditions for 1623 h, until water collection
ceased. The reaction was then diluted with 30 mL of H2O and
30 mL of methyl t-butyl ether, and the layers separated. The
organic phase was then washed sequentially with 10% aqueous
NaHCO3, brine, and H2O (30 mL each), then dried over
Na2SO4, and the solvent removed by rotary evaporation
(8096% yield). The crude product was used without purifica-
tion in the next step.
Scheme 1. Synthesis of Ethyl 2-Carbethoxy-3-cyano-3-sub-
stituted Propionate Substrates
Table 1. Yields for the Knoevenagel and Addition Reactions
entry R yield 1 (%)ref yield 2 (%)ref
aa Me 847 788
b Et 809 8310
ca i-Pr 6911 8312
d n-Pr 917 8413
eb i-Bu 8914 94
f n-Bu 967 76
gb Ph 927 63
h Bn 9315 65
i Ph(CH2)2— 94
14 64
j p-anisyl 937 67
ka 4-pyridyl 95 69
aDenotes 1 is commercially available. b 2 is commercially available.
Scheme 2. Enzymatic Kinetic Resolution of 2
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Generalized Procedure for 3-Substituted-3-cyano-2-
(ethoxycarbonyl)propanoic Acid Ethyl Esters (2). The crude
propenoic acid ester 1 is dissolved in ethanol (∼40% w/v); to this
solution is added solid KCN (0.96 equiv). The resulting slurry is
stirred at reflux for 1620 h. After reflux, the mixture is diluted
with 1 volume of MTBE and treated with glacial acetic acid (1.0
equiv) in water (1 volume). The layers are separated, the organic
phase washed with brine (2 1 volume portions), and the solvent
removed by rotary evaporation under vacuum. This product can be
used crude in the enzymatic resolution.
Generalized Procedure for Screening 3-Substituted-3-
cyanopropanoic Acid Ethyl Esters (4). Ten microliters of 2
were suspended in 1.0 mL of potassium phosphate buffer at
pH 7.0 (0.10M). To this was added 1 μL of enzyme solution, and
the mixture stirred and maintained at 30.0 C for 1623 h. The
mixture was then extracted with 3 mL of MTBE to remove the
undesired enantiomer. The aqueous layer containing the potas-
sium salt of 3 was refluxed for 12 h, causing an insoluble
product to settle over the aqueous layer. The resulting solution
was extracted with 1 mL of MTBE and washed with water
(1 mL), leaving the desired enantiopure ethyl 3-substituted-3-
cyanopropionate 4. The procedure as given is satisfactory for
small substrate loads. At higher substrate concentrations, a
decrease in activity is observed, because of enzyme inhibition
by the carboxylate salts 3. In such cases, the addition of 10%
molar equivalent of Ca(OAc)2 or Zn(OAc)2 serves to restore full
enzymatic activity. Further discussion of this phenomenon may
be found in ref 3. Additionally, the use of buffer solution becomes
impractical; pH control by means of an autotitrator (with 4N
NaOH) is preferred.
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